Funder: The Association for Frontotemporal Degeneration
Due Dates: March 6, 2026 (Letter of Intent) | May 12, 2026 (Full Proposal)
Funding Amounts: $250,000–$700,000 total per award (up to 2 years); up to 10% indirect costs for academic/nonprofit institutions.
Summary: Supports research to develop and validate biomarkers that improve the diagnosis of frontotemporal lobar degeneration (FTLD).
Key Information: Postdocs cannot apply as lead PI; open to academic, nonprofit, and for-profit investigators worldwide.